Clinical Trials Browser

Phase 1/2 × NIH × B3(Fv)-PE38KDEL recombinant immunotoxin × Clear all

NCT00924170 2023-11-14

Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia

Phase 1/2 Completed

18 enrolled 30 charts

LymphoidOther hematologic neoplasm

Leukemia, Leukemia-Lymphoma, Adult T-Cell